Abcellera Biologics Inc (ABCL)

Jan 13, 2025, 9:00 AM EST - 4 days ago

AbCellera Expands Collaboration with AbbVie to Develop Novel T-Cell Engagers for Oncology

Dec 23, 2024, 4:39 PM EST - 25 days ago

AbCellera Biologics: Still A Concept Stock

Nov 21, 2024, 4:05 PM EST - 2 months ago

AbCellera to Present at Upcoming Investor Conferences in December and January

Nov 7, 2024, 10:05 AM EST - 2 months ago

AbCellera Presents Data on Applications of T-Cell Engager Platform at SITC 2024

Nov 4, 2024, 7:22 PM EST - 2 months ago

AbCellera Biologics Inc. (ABCL) Q3 2024 Earnings Call Transcript

Nov 4, 2024, 4:05 PM EST - 2 months ago

AbCellera Reports Q3 2024 Business Results

Oct 22, 2024, 4:05 PM EDT - 3 months ago

AbCellera to Present at Upcoming Investor Conferences in November 2024

Oct 14, 2024, 12:04 PM EDT - 3 months ago

AbCellera: A Platform To Pipeline Transition

Oct 4, 2024, 9:00 AM EDT - 3 months ago

AbCellera Announces Presentation on T-cell Engager Platform at the Society for Immunotherapy of Cancer (SITC) Annual Meeting 2024

Sep 26, 2024, 4:05 PM EDT - 4 months ago

AbCellera to Report Third Quarter 2024 Financial Results on November 4, 2024

Aug 29, 2024, 4:05 PM EDT - 5 months ago

AbCellera to Present at Upcoming Investor Conferences in September

Aug 23, 2024, 4:43 AM EDT - 5 months ago

AbCellera: A Waiting Game With High Uncertainty

Aug 20, 2024, 9:45 AM EDT - 5 months ago

This Globant Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday

GLOB AVDX LRN PGRU

Aug 6, 2024, 4:05 PM EDT - 5 months ago

AbCellera Reports Q2 2024 Business Results

Jul 31, 2024, 9:00 AM EDT - 6 months ago

AbCellera and Lilly Expand Collaboration to Develop Antibody Medicines

Jun 25, 2024, 4:05 PM EDT - 7 months ago

AbCellera to Report Second Quarter 2024 Financial Results on August 6, 2024

May 28, 2024, 4:05 PM EDT - 8 months ago

AbCellera to Present at the Goldman Sachs 45th Annual Global Healthcare Conference on June 10, 2024

May 7, 2024, 11:00 PM EDT - 9 months ago

AbCellera Biologics Inc. (ABCL) Q1 2024 Earnings Call Transcript

May 7, 2024, 4:05 PM EDT - 9 months ago

AbCellera Reports Q1 2024 Business Results

May 1, 2024, 9:00 AM EDT - 9 months ago

AbCellera, Viking Global Investors, and ArrowMark Partners Collaborate to Launch New Biotech Companies

Apr 8, 2024, 12:05 PM EDT - 10 months ago

AbCellera Presents Data on T-Cell Engagers Against Four Tumor Targets at AACR 2024

Apr 3, 2024, 4:05 PM EDT - 10 months ago

AbCellera to Report First Quarter 2024 Financial Results on May 7, 2024

Mar 19, 2024, 4:05 PM EDT - 10 months ago

AbCellera to Present at the Bloom Burton Healthcare Conference on April 16, 2024

Mar 11, 2024, 9:00 AM EDT - 11 months ago

AbCellera to Collaborate with Biogen to Discover Therapeutic Antibodies for Neurological Conditions

BIIB

Mar 5, 2024, 4:30 PM EST - 11 months ago

AbCellera Announces Four Presentations on T-Cell Engagers at AACR 2024

Feb 23, 2024, 4:30 PM EST - 11 months ago

AbCellera Announces Resignation of Board Member

Feb 22, 2024, 8:15 PM EST - 11 months ago

AbCellera to Present at Upcoming Investor Conferences in March

Feb 20, 2024, 11:45 PM EST - 11 months ago

AbCellera Biologics Inc. (ABCL) Q4 2023 Earnings Call Transcript

Feb 20, 2024, 4:05 PM EST - 11 months ago

AbCellera Reports Full Year 2023 Business Results

Jan 23, 2024, 4:05 PM EST - 1 year ago

AbCellera to Report Full Year 2023 Financial Results on February 20, 2024

Dec 20, 2023, 4:05 PM EST - 1 year ago

AbCellera to Present at the 42nd Annual J.P. Morgan Healthcare Conference on January 10, 2024

Dec 7, 2023, 11:39 PM EST - 1 year ago

Buy AbCellera Biologics's Revolutionizing AI-Powered Drug Development Platform

Nov 16, 2023, 4:05 PM EST - 1 year ago

AbCellera to Present at the Piper Sandler 35th Annual Healthcare Conference on November 30, 2023

Nov 3, 2023, 12:05 PM EDT - 1 year ago

AbCellera Presents New Data on Two T-Cell Engager Programs at SITC 2023

Nov 2, 2023, 9:18 PM EDT - 1 year ago

AbCellera Biologics Inc. (ABCL) Q3 2023 Earnings Call Transcript

Nov 2, 2023, 4:05 PM EDT - 1 year ago

AbCellera Reports Q3 2023 Business Results

Nov 1, 2023, 4:05 PM EDT - 1 year ago

Prelude Therapeutics and AbCellera Enter Partnership to Develop First-in-Class Precision Antibody Drug Conjugates in Oncology

Oct 31, 2023, 4:05 PM EDT - 1 year ago

AbCellera to Present at the Jefferies London Healthcare Conference on November 14, 2023

Oct 11, 2023, 4:05 PM EDT - 1 year ago

AbCellera to Report Third Quarter 2023 Financial Results on November 2, 2023

Sep 27, 2023, 9:00 AM EDT - 1 year ago

AbCellera Announces Two T-Cell Engager Presentations at SITC 2023

Sep 20, 2023, 9:00 AM EDT - 1 year ago

AbCellera Expands Multi-Target Antibody Discovery Collaboration with Regeneron

Sep 13, 2023, 9:00 AM EDT - 1 year ago

AbCellera Announces Collaboration with Incyte to Accelerate the Discovery and Development of Therapeutic Antibodies in Oncology

Aug 3, 2023, 11:03 PM EDT - 1 year ago

AbCellera Biologics Inc. (ABCL) Q2 2023 Earnings Call Transcript

Aug 3, 2023, 4:05 PM EDT - 1 year ago

AbCellera Reports Q2 2023 Business Results

Jul 24, 2023, 4:05 PM EDT - 1 year ago

AbCellera Announces that the U.S. Patent Trial and Appeal Board Has Denied Berkeley Lights' Request for Rehearing

Jul 6, 2023, 4:05 PM EDT - 1 year ago

AbCellera to Report Second Quarter 2023 Financial Results on August 3, 2023

Jun 15, 2023, 5:00 AM EDT - 1 year ago

Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera

May 29, 2023, 4:05 PM EDT - 1 year ago

AbCellera to Present at the Goldman Sachs 44th Annual Global Healthcare Conference on June 13, 2023

May 24, 2023, 1:10 PM EDT - 1 year ago

AbCellera Partners with the Governments of Canada and British Columbia to Advance Drug Development Capabilities and Infrastructure that Will Accelerate Innovative Medicines to Patients

May 6, 2023, 12:42 AM EDT - 1 year ago

AbCellera Biologics: TCE Program Alone Could Be Worth More Than The Current Market Cap